Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)
Germany flag Germany · Delayed Price · Currency is EUR
2.060
+0.020 (0.98%)
At close: Dec 5, 2025

Guangzhou Baiyunshan Pharmaceutical Holdings Company Company Description

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials.

The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health preservation and elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services.

It operates through retail chain pharmacy outlets and retail stores. The company operates in the People’s Republic of China and internationally.

The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Country China
Founded 1997
Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Employees 27,425
CEO Hong Li

Contact Details

Address:
No. 45, Sha Mian North Street
Guangzhou, 510130
China
Phone 86 20 6628 1218
Website gybys.com.cn

Stock Details

Ticker Symbol GU5
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 5122

Key Executives

Name Position
Hong Li Chief Executive Officer
Liu Fei Chief Financial Officer